Bloomios Inc
OTC:BLMS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Bloomios Inc
Total Liabilities
Bloomios Inc
Total Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
B
|
Bloomios Inc
OTC:BLMS
|
Total Liabilities
$27.3m
|
CAGR 3-Years
286%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Dupont De Nemours Inc
NYSE:DD
|
Total Liabilities
$7.7B
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
N/A
|
|
|
Bellring Brands Inc
NYSE:BRBR
|
Total Liabilities
$1.6B
|
CAGR 3-Years
12%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
|
|
Balchem Corp
NASDAQ:BCPC
|
Total Liabilities
$428.8m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
5%
|
CAGR 10-Years
0%
|
|
|
Cyclo Therapeutics Inc
NASDAQ:CYTH
|
Total Liabilities
$18.7m
|
CAGR 3-Years
75%
|
CAGR 5-Years
51%
|
CAGR 10-Years
34%
|
|
|
T
|
Trulieve Cannabis Corp
CNSX:TRUL
|
Total Liabilities
$1.5B
|
CAGR 3-Years
1%
|
CAGR 5-Years
33%
|
CAGR 10-Years
N/A
|
|
Bloomios Inc
Glance View
Bloomios, Inc. is a blank check company, which engages in pursuing potential new business opportunity by way of a merger and acquisition with an unidentified company, an acquisition of assets, and other form of business combination. The company is headquartered in Santa Barbara, California. The company went IPO on 2003-10-14. The firm is engaged in the growing, processing, extraction, and manufacture of cannabidiol (CBD) products. The firm sells its products to business to business (B2B) customers.
See Also
What is Bloomios Inc's Total Liabilities?
Total Liabilities
27.3m
USD
Based on the financial report for Dec 31, 2022, Bloomios Inc's Total Liabilities amounts to 27.3m USD.
What is Bloomios Inc's Total Liabilities growth rate?
Total Liabilities CAGR 3Y
286%
Over the last year, the Total Liabilities growth was 390%. The average annual Total Liabilities growth rates for Bloomios Inc have been 286% over the past three years .
